Citius Pharmaceuticals Inc
(CTXR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Operating Expenses | 38,526 | 41,996 | 36,732 | 33,316 | 23,532 |
| Operating Income | -38,526 | -41,996 | -36,732 | -33,316 | -23,532 |
| Interest Expense | 268 | 0 | 0 | 0 | 11 |
| Other Income | 110 | 3,146 | 4,765 | 251 | 488 |
| Pre-tax Income | -38,683 | -38,850 | -31,967 | -33,065 | -23,054 |
| Income Tax | 1,057 | 576 | 576 | 576 | N/A |
| Net Income Continuous | -39,740 | -39,426 | -32,543 | -33,641 | -23,054 |
| Minority Interests | -2,306 | -287 | N/A | N/A | N/A |
| Net Income | $-37,434 | $-39,139 | $-32,543 | $-33,641 | $-23,054 |
| EPS Basic Total Ops | -3.38 | -5.97 | -5.57 | -5.75 | -5.75 |
| EPS Basic Continuous Ops | -3.59 | -5.86 | -5.38 | -5.76 | -5.31 |
| EPS Diluted Total Ops | -3.38 | -5.97 | -5.57 | -5.75 | -5.75 |
| EPS Diluted Continuous Ops | -3.59 | -5.86 | -5.38 | -5.76 | -5.31 |
| EPS Diluted Before Non-Recurring Items | -3.38 | -5.97 | -6.00 | -5.75 | -5.75 |
| EBITDA(a) | $-38,311 | $-41,786 | $-36,538 | $-33,136 | $-23,367 |